Project Details
| Status | Active |
|---|---|
| Effective start/end date | 06/6/22 → 01/21/27 |
Funding
- Genentech Incorporated: $112,844.00
IQVIA RDS: A Multicenter, Single-Arm, Open-Label, Extension, Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab in Patients with Multiple Sclerosis
- Coyle, Patricia K (PI)
- McLinskey, Nancy (CoPI)
- Melville, Patricia (CoPI)
- Syritsyna, Olga (CoPI)
Project: Research